P2 receptor web: Complexity and fine-tuning

Pharmacology and Therapeutics

Volumn 112, Issue 1, 2006, Pages 264-280

  Volonté, Cinzia ^a   Amadio, Susanna ^a   D'Ambrosi, Nadia ^a   Colpi, Monica ^b   Burnstock, Geoffrey ^c  

^a CNR   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Combinatorial calculation; Ionotropic P2X receptor; Metabotropic P2Y receptor; Receptor cross talk; Receptor web

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 CHLOROADENOSINE 5' TRIPHOSPHATE; 3' O (4 BENZOYLBENZOYL)ADENOSINE TRIPHOSPHATE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5' ADENYLYL BETA GAMMA IMIDODIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALMIDAZOLIUM; COPPER; DIADENOSINE PENTAPHOSPHATE; MAGNESIUM; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NF 279; PURINE P2 RECEPTOR; PURINE P2X RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; UNCLASSIFIED DRUG; ZINC;

BINDING AFFINITY; CELL SURFACE; CELLULAR DISTRIBUTION; ELECTRON MICROSCOPE; EPIGENETICS; EXTRACELLULAR CALCIUM; GENE CONTROL; GENETIC COMPATIBILITY; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; PROTEIN SUBUNITS; RECEPTOR CROSS-TALK; RECEPTORS, PURINERGIC P2;

EID: 33748042976     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.04.012     Document Type: Review

References (161)

1. 14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24 (2003) 52-55
2. Abbracchio, M. P., Burnstock, G., Boeynaems, J. M., Barnard, E. A., Boyer, J. L., Kennedy, C., et al. (in press). Update of the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev.
3. Afework M., and Burnstock G. Changes in P2Y2 receptor localization on adrenaline- and noradrenaline-containing chromaffin cells in the rat adrenal gland during development and aging. Int J Dev Neurosci 23 (2005) 567-573
4. 2 adenosine receptors in cultured cortical astrocytes. Br J Pharmacol 141 (2004) 935-942
5. Amadio S., D'Ambrosi N., Cavaliere F., Murra B., Sancesario G., Bernardi G., et al. P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology 42 (2002) 489-501
6. Amadio S., D'Ambrosi N., Trincavelli L., Tuscano D., Sancesario G., Bernardi G., et al. Differences in the neurotoxicity profile induced by ATP and ATPγS in cerebellar granule nerons. Neurochem Int 47 (2005) 334-342
7. 2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation. Proc Natl Acad Sci USA 102 (2005) 19138-19143
8. 1 + 2 receptor subtypes. J Mol Biol 342 (2004) 333-343
9. 1 ATP-gated currents by 5-hydroxytryptamine 2A receptors involves diacylglycerol-dependent kinases and intracellular calcium. J Pharmacol Exp Ther 315 (2005) 144-154
10. 4 receptor subunit immunoreactivity to pre- and post-synaptic neuronal elements and glial processes in the dorsal vagal complex of the rat. Brain Res 1026 (2004) 44-55
11. Atkinson L., Milligan C.J., Buckley N.J., and Deuchars J. Purinergic receptors: an ATP-gated ion channel at the cell nucleus. Nature 420 (2002) 42
12. 6 in patients undergoing heart transplantation, interaction with TNFα and potential role in myocardial cell death. J Mol Cell Cardiol 39 (2005) 929-939
13. Battaglia A.A., Sehayek K., Grist J., McMahon S.B., and Gavazzi I. EphB receptors and ephrin-B ligands regulate spinal sensory connectivity and modulate pain processing. Nat Neurosci 6 (2003) 339-340
14. Becher A., White J.H., and McIlhinney R.A. The gamma-aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum. J Neurochem 79 (2001) 787-795
15. Belous A., Wakata A., Knox C.D., Nicoud I.B., Pierce J., Anderson C.D., et al. Mitochondrial P2Y-like receptors link cytosolic adenosine nucleotides to mitochondrial calcium uptake. J Cell Biochem 92 (2004) 1062-1073
16. Bender E., Buist A., Jurzak M., Langlois X., Baggerman G., Verhasselt P., et al. Characterization of an orphan G protein-coupled receptor localized in the dorsal root ganglia reveals adenine as a signaling molecule. Proc Natl Acad Sci USA 99 (2002) 8573-8578
17. Bianco F., Fumagalli M., Pravettoni E., D'Ambrosi N., Volonté C., Matteoli M., et al. Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia. Brain Res Rev 48 (2005) 144-156
18. Bodin P., and Burnstock G. Purinergic signalling: ATP release. Neurochem Res 26 (2001) 959-969
19. Boeynaems J.M., Communi D., Gonzalez N.S., and Robaye B. Overview of the P2 receptors. Semin Thromb Hemost 31 (2005) 139-149
20. 2 ATP-gated channels. J Biol Chem 275 (2000) 10190-10195
21. Brake A.J., Wagenbach M.J., and Julius D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature 371 (1994) 519-523
22. Brown S.G., Townsend-Nicholson A., Jacobson K.A., Burnstock G., and King B.F. Heteromultimeric P2X1/2 receptors show a novel sensitivity to extracellular pH. J Pharmacol Exp Ther 300 (2002) 673-680
23. Bruckner K., Pablo Labrador J., Scheiffele P., Herb A., Seeburg P.H., and Klein R. EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron 22 (1999) 511-524
24. Brusès J.L., Chauvet N., and Rutishauser U. Membrane lipid rafts are necessary for the maintenance of the α7 nicotinic acetylcholine receptor in somatic spines of ciliary neurons. J Neurosci 21 (2001) 504-512
25. 7 receptor function with a monoclonal antibody. Blood 92 (1998) 3521-3528
26. Burnstock G. Purinoceptors: ontogeny and phylogeny. Drug Dev Res 39 (1996) 204-242
27. Burnstock G. Introduction: P2 receptors. Curr Top Med Chem 4 (2004) 793-803
28. Burnstock G. Cotransmission. Curr Opin Pharmacol 4 (2004) 47-52
29. Burnstock G. Vessel tone and remodeling. Nat Med 12 (2006) 16-17
30. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58 (2006) 58-86
31. Burnstock, G. (2006c). Purinergic P2 receptors as targets for novel analgesics. Pharmacol Therapeut Epub ahead of print 11/10/05.
32. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol Sci 27 (2006) 166-176
33. Burnstock G., and Knight G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240 (2004) 31-304
34. Canals M., Marcellino D., Fanelli F., Ciruela F., de Benedetti P., Goldberg S.R., et al. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 278 (2003) 46741-46749
35. 7 purinoceptor by 17β-oestradiol. J Physiol 508 (1998) 659-666
36. Cattaneo M. The P2 receptors and congenital platelet function defects. Semin Thromb Hemost 31 (2005) 168-173
37. Cavaliere F., D'Ambrosi N., Ciotti M.T., Mancino G., Sancesario G., Bernardi G., et al. Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists. Neurochem Int 38 (2001) 189-197
38. Cavaliere F., D'Ambrosi N., Sancesario G., Bernardi G., and Volonté C. Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue. Neurochem Int 38 (2001) 199-207
39. Cavaliere F., Sancesario G., Bernardi G., and Volonté C. Extracellular ATP and nerve growth factor intensify hypoglycemia-induced cell death in primary neurons: role of P2 and NGFRp75 receptors. J Neurochem 83 (2002) 1129-1138
40. 4 receptors during ischemic cell death: prevention by P2 antagonists. Neuroscience 120 (2003) 85-98
41. Cavaliere F., Amadio S., Sancesario G., Bernardi G., and Volonté C. Synaptic P2X7 and oxygen/glucose deprivation in hippocampal organotypic cultures. J Cerebr Blood F Met 24 (2004) 392-398
42. 4 receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor. Exp Cell Res 300 (2004) 149-158
43. 4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells. Neurobiol Dis 18 (2005) 100-109
44. Chaumont S., Jiang L.H., Penna A., North R.A., and Rassendren F. Identification of a trafficking motif involved in the stabilization and polarization of P2X receptors. J Biol Chem 279 (2004) 29628-29638
45. Cheung K.K., Chan W.Y., and Burnstock G. Expression of P2X purinoceptors during rat brain development and their inhibitory role on motor axon outgrowth in neural tube explant cultures. Neuroscience 133 (2005) 937-945
46. Chizhmakov I., Yudin Y., Mamenko N., Prudnikov I., Tamarova Z., and Krishtal O. Opioids inhibit purinergic nociceptors in the sensory neurons and fibres of rat via a G protein-dependent mechanism. Neuropharmacology 48 (2005) 639-647
47. Choi R.C., Wong C.S.S., Simon J., and Barnard E.A. Agonist-induced homo-dimerisation of P2Y1 receptors demonstrated by fluorescence resonance energy transfer analysis. Br J Pharmacol 146 (2005) 11P
48. Chootip K., Kennedy C., and Guerney A.M. Characterization of P2 receptors mediating contraction of the rat isolated pulmonary vasculature. Br J Pharmacol 131 (2000) 167P
49. 2 purinoceptor by zinc and pH. J Physiol 539 (2002) 347-359
50. 6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J Neurosci 16 (1996) 2495-2507
51. i. J Biol Chem 276 (2001) 41479-41485
52. Costanzi S., Mamedova L., Gao Z.G., and Jacobson K.A. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. J Med Chem 47 (2004) 5393-5404
53. D'Ambrosi N., Cavaliere F., Merlo D., Milazzo L., Mercanti D., and Volonté C. Antagonists of P2 receptors prevent NGF-dependent neuritogenesis in PC12 cells. Neuropharmacology 39 (2000) 1083-1094
54. D'Ambrosi N., Murra B., Cavaliere F., Amadio S., Bernardi G., Burnstock G., et al. Interaction between ATP and nerve growth factor signalling in the survival and neuritic outgrowth from PC12 cells. Neuroscience 108 (2001) 527-534
55. D'Ambrosi N., Costanzi S., Angelini D.F., Volpini R., Sancesario G., Cristalli G., et al. 2-ChloroATP exerts antitumoral actions not mediated by P2 receptors in neuronal and glial cell lines. Biochem Pharmacol 67 (2004) 621-630
56. D'Ambrosi N., Iafrate M., Vacca F., Amadio S., Tozzi A., Mercuri N.B., et al. P2Y receptors form oligomeric complexes in several CNS and PNS neuronal cells. Purine Club Meeting, Chieti, Italy, Abst #7 (2005)
57. 7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci 21 (2001) 7143-7152
58. Di Virgilio F., Chiozzi P., Falzoni S., Ferrari D., Sanz J.M., Venketaraman V., et al. Cytolytic P2X purinoceptors. Cell Death Differ 5 (1998) 191-199
59. Di Virgilio F., Chiozzi P., Ferrari D., Falzoni S., Sanz J.M., Morelli A., et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97 (2001) 587-600
60. Di Virgilio F., Baricordi O.R., Romagnoli R., and Baraldi P.G. Leukocyte P2 receptors: a novel target for anti-inflammatory and anti-tumor therapy. Curr Drug Targets Cardiovasc Haematol Disord 5 (2005) 85-99
61. Erlinge D., Hou M., Webb T.E., Barnard E.A., and Moller S. Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem Biophys Res Comm 248 (1998) 864-870
62. Evans R.J., Lewis C., Virginio C., Lundstrom K., Buell G., Surprenant A., et al. Ionic permeability and divalent cation effects on two ATP-gated cation channels (P2X receptors) expressed in mammalian cells. J Physiol 497 (1996) 413-422
63. 7 receptor?. Am J Physiol Cell Physiol 288 (2005) C260-C271
64. 2 purinergic receptors in precerebellar nuclei. Neuroscience 115 (2002) 425-434
65. Franke H., and Illes P. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol Therapeut 109 (2006) 297-324
66. Franke H., Krugel U., Grosche J., Heine C., Hartig W., Allgaier C., et al. P2Y receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience 127 (2004) 431-441
67. 7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropath Exp Neurol 63 (2004) 686-699
68. 1 and P2Y receptor stimulation on calcium mobilization and PKC translocation in DDT1 MF-2 cells. Cell Mol Neurobiol 23 (2003) 379-400
69. Gallagher J.A. ATP P2 receptors and regulation of bone effector cells. J Musculoskelet Neur Interact 4 (2004) 125-127
70. Garcia-Guzman M., Soto F., Laube B., and Stühmer M. Molecular cloning and functional expression of a novel rat heart P2X purinoceptor. FEBS Lett 388 (1996) 123-127
71. 4 receptor reveals pharmacological differences to the rat receptor. Mol Pharmacol 51 (1997) 109-118
72. Gines S., Hillion J., Torvinen M., Le Crom S., Casado V., Canela E.I., et al. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci USA 97 (2000) 8606-8611
73. Gomez-Villafuertes R., Pintor J., Gualix J., and Miras-Portugal M.T. GABAB receptor-mediated presynaptic potentiation of ATP ionotropic receptors in rat midbrain synaptosomes. Neuropharmacology 44 (2003) 311-323
74. Gorzalka S., Vittori S., Volpini R., Cristalli G., von Kugelgen I., and Muller C.E. Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues. Mol Pharmacol 67 (2005) 955-964
75. Guzman S.J., Gerevich Z., Hengstler J.G., Illes P., and Kleemann W. P2Y1 receptors inhibit both strength and plasticity of glutamatergic synaptic neurotransmission in the rat prefrontal cortex. Synapse 57 (2005) 235-238
76. Haines W.R., Torres G.E., Voigt M.M., and Egan T.M. Properties of the novel ATP-gated ionotropic receptor composed of the P2X1 and P2X5 isoforms. Mol Pharmacol 56 (1999) 720-727
77. Heine C., Heimrich B., Vogt J., Wegner A., Illes P., and Franke H. P2 receptor-stimulation influences axonal outgrowth in the developing hippocampus in vitro. Neuroscience 138 (2006) 303-311
78. Hervàs C., Perez-Sen R., and Miras-Portugal M.T. Coexpression of functional P2X and P2Y nucleotide receptors in single cerebellar granule cells. J Neurosci Res 73 (2003) 384-399
79. Hogg R.C., Chipperfield H., Whyte K.A., Stafford M.R., Hansen M.A., Cool S.M., et al. Functional maturation of isolated neural progenitor cells from the adult rat hippocampus. Eur J Neurosci 19 (2004) 2410-2420
80. 2-receptor mRNA levels in congestive heart failure. Life Sciences 65 (1999) 1195-1206
81. 1 receptors. Br J Pharmacol. 147 (2006) 459-467
82. Illes P., and Ribeiro J.A. Molecular physiology of P2 receptors in the central nervous system. Eur J Pharmacol 483 (2004) 5-17
83. Jacobson K.A., Costanzi S., Ohno M., Joshi B.V., Besada P., Xu B., et al. Molecular recognition at purine and pyrimidine nucleotide (P2) receptors. Curr Top Med Chem 4 (2004) 805-819
84. 2+ signalling in glial cell pathology in the central nervous system. Eur J Pharmacol 447 (2002) 247-260
85. Jiang L.H., Kim M., Spelta V., Bo X., Surprenant A., and North R.A. Subunit arrangement in P2X receptors. J Neurosci 23 (2003) 8903-8910
86. 3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res 823 (1999) 183-190
87. 2 receptors in living cells. Biochem Biophys Res Comm 306 (2003) 544-549
88. 1 receptors in the hippocampal slice. J Neurosci 24 (2004) 10835-10845
89. Khakh B.S., Bao X.R., La barca C., and Lester H.A. Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds. Nat Neurosci 2 (1999) 322-330
90. 2 and α4β2 nicotinic channels measured with fluorescence resonance energy transfer and total internal reflection fluorescence microscopy. J Neurosci 25 (2005) 6911-6920
91. Kennedy C. P2X receptors: targets for novel analgesics?. Neuroscientist 11 (2005) 345-356
92. 2 receptor. Br J Pharmacol 121 (1997) 1445-1453
93. 6 subunits in Xenopus oocytes. J Neurosci 20 (2000) 4871-4877
94. 1 receptor-mediated nitric oxide production. Neuropsychopharmacology 28 (2003) 435-444
95. 7 receptors. Eur J Pharmacol 387 (2000) 245-252
96. Koles L., Furst S., and Illes P. P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses. Drug News Perspect 18 (2005) 85-101
97. α16 and evidence for receptor oligomers. Cell Signal 17 (2005) 869-880
98. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19 (1996) 312-318
99. Lambrecht G., Braun K., Damer M., Ganso M., Hildebrandt C., Ullmann H., et al. Structure-activity relationships of suramin and pyridoxal-5′-phosphate derivatives as P2 receptor antagonists. Curr Pharm Design 8 (2002) 2371-2399
100. 6 channel subunits coassemble into a novel heteromeric ATP receptor. J Neurosci 18 (1998) 7152-7159
101. Ledesma M.D., Simons K., and Dotti C.G. Neuronal polarity: essential role of protein-lipid complexes in axonal sorting. Proc Natl Acad Sci USA 95 (1998) 3966-3971
102. 14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells. Genes Dev 17 (2003) 1592-1604
103. Lemoli R.M., Ferrari D., Fogli M., Rossi L., Pizzirani C., Forchap S., et al. Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo. Blood 104 (2004) 1662-1670
104. 3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature 377 (1995) 432-435
105. Lisanti M.P., Scherer P.E., Vidugiriene J., Tang Z., Hermanowski-Vosatka A., Tu Y.H., et al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol 126 (1994) 111-126
106. 3 receptors in rat sensory neurons. NeuroReport 9 (1998) 2545-2550
107. 1 receptors in the rat cerebellum. Cell Tiss Res 294 (1998) 253-260
108. 6 receptors in the rat hypothalamo-neurohypophysial system: an ultrastructural study with extravidin and colloidal gold-silver labelling. Neuroscience 106 (2001) 621-631
109. 2 receptor immunoreactivity in the rat hypothalamo-neurohypophysial system. J Neurocytol 28 (1999) 495-504
110. Luttikhuizen D.T., Harmsen M.C., de Leij L.F., and van Luyn M.J. Expression of P2 receptors at sites of chronic inflammation. Cell Tissue Res 317 (2004) 289-298
111. Mason H.S., Bourke S., and Kemp P.J. Selective modulation of ligand-gated P2X purinoceptor channels by acute hypoxia is mediated by reactive oxygen species. Mol Pharmacol 66 (2004) 1525-1535
112. Melani A., Turchi D., Vannucchi M.G., Cipriani S., Gianfriddo M., and Pedata F. ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem Int 47 (2005) 442-448
113. 7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J Cerebr Blood F Met (Electronic publication ahead of print, 4/1/06).
114. Minghetti L., Polazzi E., Nicolini A., Greco A., and Levi G. Possible role of microglial prostanoids and free radicals in neuroprotection, neurodegeneration. Adv Exp Med Biol 468 (1999) 109-119
115. Moudgil V., Kruczak V., Eessalu T., Paulose C.S., Taylor M., and Hansen J. Activation of progesterone receptor by ATP. Eur J Biochem 118 (1981) 547-555
116. Nakata H., Yoshioka K., and Kamiya T. Purinergic-receptor oligomerization: implications for neural functions in the central nervous system. Neurotox Res 6 (2004) 291-297
117. Nakata H., Yoshioka K., Kamiya T., Tsuga H., and Oyanagi K. Functions of heteromeric association between adenosine and P2Y receptors. J Mol Neurosci 26 (2005) 233-238
118. Neary J.T., Rathbone M.P., Cattabeni F., Abbracchio M.P., and Burnstock G. Trophic actions of extracellular nucleotides and nucleosides on glial, neuronal cells. Trends Neurosci 19 (1996) 13-18
119. Neary J.T., Kang Y., Tran M., and Feld J. Traumatic injury activates protein kinase B/Akt in cultured astrocytes: role of extracellular ATP and P2 purinergic receptors. J Neurotraum 22 (2005) 491-500
120. 3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J 17 (1998) 3016-3028
121. 4 subunits. J Neurochem 92 (2005) 925-933
122. North R.A. Molecular physiology of P2X receptors. Physiol Rev 82 (2002) 1013-10167
123. Oka N., Yamamoto M., Schwencke C., Kawabe J., Ebina T., Ohno S., et al. Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem 272 (1997) 33416-33421
124. Phillis J.W., O'Regan M.H., and Perkins L.M. Adenosine 5′-triphosphate release from the normoxic and hypoxic in vivo rat cerebral cortex. Neurosci Lett 151 (1993) 94-96
125. 3 receptor subunits in rat carotid body afferent neurones: role in chemosensory signalling. J Physiol 537 (2001) 667-677
126. 3 receptors. J Neurosci 17 (1997) 6529-6533
127. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50 (1998) 413-492
128. 1 receptors. Contribution of aromatic and basic amino acids revealed using mutagenesis and partial agonists. J Biol Chem 279 (2004) 9043-9055
129. Rubio M.E., and Soto F. Distinct Localization of P2X receptors at excitatory postsynaptic specializations. J Neurosci 21 (2001) 641-653
130. 12 in microglia in rat brain. Glia 44 (2003) 242-250
131. 5 receptor subunit expression and function in rat thoracolumbar sympathetic neurons. J Neurochem 79 (2001) 997-1003
132. 2 receptor. Mol Pharmacol 52 (1997) 237-248
133. Slater N.M., Barden J.A., and Murphy C.R. Distributional changes of purinergic receptor subtypes (P2X1-7) in uterine epithelial cells during early pregnancy. Histochem J 32 (2000) 365-372
134. Smith N.C.E., and Burnstock G. Mechanisms underlying postjunctional synergism between responses of the vas deferens to noradrenaline and ATP. Eur J Pharmacol 498 (2004) 241-248
135. Sokolova E., Nistri A., and Giniatullin R. Negative cross talk between anionic GABAA and cationic P2X ionotropic receptors of rat dorsal root ganglion neurons. J Neurosci 21 (2001) 4958-4968
136. Song Z., and Sladek C.D. Site of ATP and phenylephrine synergistic stimulation of vasopressin release from the hypothalamo-neurohypophyseal system. J Neuroendocrinol 18 (2006) 266-272
137. Soto F., Garcia-Guzman M., Karschin C., and Stuhmer W. Cloning and tissue distribution of a novel P2X receptor from rat brain. Biochem Biophys Res Comm 223 (1996) 456-460
138. 2 receptor in mouse pineal gland tumor cells. J Neurochem 77 (2001) 1475-1485
139. 7). Science 272 (1996) 735-738
140. 1/5 receptors expressed in HEK cells and excitatory junction potentials in guinea pig submucosal arterioles. J Auton Nerv Syst 81 (2000) 249-263
141. Tanoue A., Koshimizu T., Tsujimoto G., Nakata H., Hirose S., Fukuzawa T., et al. Heterogeneity of G protein-coupled receptor generated by post-translational mechanisms and its clinical meanings. Nipp Yakurigaku Zasshi 124 (2004) 235-243
142. 5 receptor subunits reveals a novel ATP-gated ion channel. Mol Pharmacol 54 (1998) 989-993
143. Torres G.E., Egan T.M., and Voigt M.M. Hetero-oligomeric assembly of P2X receptor subunits. Specificities exist with regard to possible partners. J Biol Chem 274 (1999) 6653-6659
144. Uckermann O., Wolf A., Kutzera F., Kalisch F., Beck-Sickinger A.G., Wiedemann P., et al. Glutamate release by neurons evokes a purinergic inhibitory mechanism of osmotic glial cell swelling in the rat retina: activation by neuropeptide Y. J Neurosci Res 83 (2006) 538-550
145. 3 receptor localizes into lipid rafts in neuronal cells. J Neurosci Res 76 (2004) 653-661
146. Vial C., Roberts J.A., and Evans R.J. Molecular properties of ATP-gated P2X receptor ion channels. Trends Pharmacol Sci 25 (2004) 487-493
147. 1 receptors does not involve direct channel phosphorylation. Biochem J 382 (2004) 101-110
148. 3 receptors and receptors in rat nodose neurones. J Physiol 510 (1998) 27-35
149. Virginio C., MacKenzie A., Rassendren F.A., North R.A., and Surprenant A. Pore dilatation of neuronal P2X receptor channels. Nature Neurosci 2 (1999) 315-322
150. Volonté C., and Merlo D. Selected P2 purinoceptor modulators prevent glutamate-evoked cytotoxicity in cultured cerebellar granule neurons. J Neurosci Res 45 (1996) 183-193
151. Volonté C., Ciotti M.T., D'Ambrosi N., Lockhart B., and Spedding M. Neuroprotective effects of modulators of P2 receptors in primary culture of CNS neurones. Neuropharmacology 38 (1999) 1335-1342
152. Volonté C., Amadio S., Cavaliere F., D'Ambrosi N., Vacca F., and Bernardi G. Extracellular ATP and neurodegeneration in the nervous system. Current Drug Targets: CNSND 2 (2003) 402-413
153. Vulchanova L., Arvidsson U., Riedl M., Wang J., and Buell G. Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry. Proc Natl Acad Sci USA 93 (1996) 8063-8067
154. Wang L., Jacobsen S.E., Bengtsson A., and Erlinge D. P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunol 5 (2004) 16
155. White N., and Burnstock G. P2 receptors and cancer. Trends Pharmacol Sci (2006) (Epub ahead of print 10/3/06)
156. White N., Ryten M., Clayton E., Butler P., and Burnstock G. P2Y purinergic receptors regulate the growth of human melanomas. Cancer Lett 224 (2005) 81-91
157. Yoshimi Y., Watanabe S., Shinomiya T., Makino A., Toyoda M., and Ikekita M. Nucleobase adenine as a trophic factor acting on Purkinje cells. Brain Res 991 (2003) 113-122
158. 1 receptors in rat brains. FEBS Lett 531 (2002) 299-303
159. Zajchowski L.D., and Robbins S.M. Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains. Eur J Biochem 269 (2002) 737-752
160. Zhao L.F., Iwasaki Y., Oki Y., Tsugita M., Taguchi T., Nishiyama M., et al. Purinergic receptor ligands stimulate pro-opiomelanocortin gene expression in AtT-20 pituitary corticotroph cells. J Neuroendocrinol 18 (2006) 273-278
161. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362 (2000) 299-309